accountMore From Businessweek Story Tools May 4 (Bloomberg) -- GlaxoSmithKline Plc, which has set aside more than $6 billion to help settle lawsuits alleging the drugmaker���s Avandia diabetes drug causes heart attacks, is poised to resolve another 1,000...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Glaxo Poised to Settle About 1,000 Avandia Suits, Lawyer Says
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account